Guidelines for the treatment of chronic heart failure

被引:83
作者
Hoppe U.C. [1 ]
Böhm M. [1 ]
Dietz R. [1 ]
Hanrath P. [1 ]
Kroemer H.K. [1 ]
Osterspey A. [1 ]
Schmaltz A.A. [1 ]
Erdmann E. [1 ]
机构
[1] Universität Zu Köln, Klinik III für Innere Medizin, 50937 Köln
来源
Zeitschrift für Kardiologie | 2005年 / 94卷 / 8期
关键词
D O I
10.1007/s00392-005-0268-4
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:488 / 509
页数:21
相关论文
共 96 条
[1]  
Athanasuleas C.L., Stanley Jr. A.W., Buckberg G.D., Dor V., DiDonato M., Blackstone E.H., Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive Endoventricular Surgery, returning Torsion Original Radius Elliptical Shape to the LV, J Am Coll Cardiol, 37, pp. 1199-1209, (2001)
[2]  
Bansch D., Antz M., Boczor S., Volkmer M., Tebbenjohanns J., Seidl K., Block M., Gietzen F., Berger J., Kuck K.H., Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT), Circulation, 105, pp. 1453-1458, (2002)
[3]  
Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., Ip J.H., Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, pp. 225-237, (2005)
[4]  
A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure, N Engl J Med, 344, pp. 1659-1667, (2001)
[5]  
Bouvy M.L., Heerdink E.R., Leufkens H.G., Hoes A.W., Predicting mortality in patients with heart failure: A pragmatic approach, Heart, 89, pp. 605-609, (2003)
[6]  
Bradley D.J., Bradley E.A., Baughman K.L., Berger R.D., Calkins H., Goodman S.N., Kass D.A., Powe N.R., Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials, JAMA, 289, pp. 730-740, (2003)
[7]  
Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., Feldman A.M., Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure, N Engl J Med, 350, pp. 2140-2150, (2004)
[8]  
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial, Lancet, 353, pp. 9-13, (1999)
[9]  
Cicoira M., Zanolla L., Rossi A., Golia G., Franceschini L., Brighetti G., Marino P., Zardini P., Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure, J Am Coll Cardiol, 40, pp. 304-310, (2002)
[10]  
Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., Tavazzi L., The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, pp. 1539-1549, (2005)